Anti-TROP2 Antibody

Synonyms: RN927C antibody
Anti-TROP2 Antibody (RN927C antibody) 是一种靶向 Trop-2 的人源单克隆抗体,对多种肿瘤细胞系具有体外抑制作用,并在小鼠胰腺 PDX、卵巢 PDX、肺 PDX 和三阴性乳腺癌 (TNB) PDX 模型中均表现出抗肿瘤活性,可用于胰腺癌、卵巢癌、肺癌及三阴性乳腺癌的研究。
Anti-TROP2 Antibody
产品编号: MS-H82390 纯度: 96.44%
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
1mg
询价
3-5 天
5mg
询价
询价
10mg
询价
询价
50mg
询价
询价
100mg
询价
询价

产品描述

Anti-TROP2 Antibody (RN927C antibody) 是一种靶向 Trop-2 的人源单克隆抗体,对多种肿瘤细胞系具有体外抑制作用,并在小鼠胰腺 PDX、卵巢 PDX、肺 PDX 和三阴性乳腺癌 (TNB) PDX 模型中均表现出抗肿瘤活性,可用于胰腺癌、卵巢癌、肺癌及三阴性乳腺癌的研究。

生物实验数据

生物活性 Anti-TROP2 Antibody (RN927C antibody) is a human monoclonal antibody targeting Trop-2 that exhibits in vitro inhibitory effects on multiple tumor cell lines, shows antitumor activity in mouse pancreatic PDX, ovarian PDX, lung PDX, and triple-negative breast cancer (TNB) PDX models, and can be used for research on pancreatic cancer, ovarian cancer, lung cancer, and triple-negative breast cancer.
体外研究
(In Vitro)

Anti-TROP2 Antibody (0.1-10 μg/mL; overnight) 诱导 Trop-2 阳性 BxPC3 胰腺癌细胞发生有丝分裂阻滞。
Anti-TROP2 Antibody (0.004-267 nM; 4 days) 可高效杀伤多种表达 Trop-2 的人类肿瘤细胞系,IC50 值达亚纳摩尔级别。

Immunofluorescence

Cell Line: BxPC3 pancreatic cancer cells, SW620 colon cancer cells
Concentration: 0.1, 1, 10 μg/mL
Incubation Time: overnight
Result: Induced a dramatic increase in phosphorylated histone H3-positive cells in Trop-2-positive BxPC3 cells at 0.1 μg/mL, indicating widespread mitotic arrest.
Caused BxPC3 cells to detach from slides due to cell death at 10 μg/mL.
Showed no increase in phosphorylated histone H3 staining in Trop-2-negative SW620 cells at 10 μg/mL compared to untreated cells.

Cell Cytotoxicity Assay

Cell Line: A431, Fadu, OVCAR3, BxPC3, Calu-3, NCI-H292, NCI-H1650, HCC-827, MDA-MB-468, Colo205, SKBR3, SW620
Concentration: 0.004-267 nM
Incubation Time: 4 days
Result: Potently killed most Trop-2-expressing cell lines (A431, Fadu, OVCAR3, BxPC3, Calu-3, NCI-H292, NCI-H1650, HCC-827, MDA-MB-468, Colo205, SKBR3 cells), with IC50 values of 0.202, 0.507, 0.56, 0.674, 0.533, 0.633, 1.92, 0.779, 0.773, 5.06, 0.42 nM.
Showed no cytotoxicity toward Trop-2-negative SW620 cells, despite free PF-06380101 payload being active against SW620 cells with an IC50 of 0.305 nM.
体内研究
(In Vivo)

Anti-TROP2 Antibody (0.75-3.0 mg/kg;静脉注射;单次推注) 诱导小鼠 BxPC3 胰腺异种移植瘤消退。
Anti-TROP2 Antibody (0.75-3.0 mg/kg;静脉注射;单次推注给药/每 2 周 1 次;共给药 2 次) 可诱导小鼠 Pan0123 胰腺 PDX 异种移植瘤消退。
Anti-TROP2 Antibody (0.75-3.0 mg/kg;静脉注射;单次推注) 诱导小鼠 Ova196756 卵巢 PDX 异种移植瘤消退并根除。
Anti-TROP2 Antibody (1.5 mg/kg;静脉注射;单次推注给药) 可诱导小鼠 TROP2 LG0476 肺癌 PDX 异种移植物持续消退。
Anti-TROP2 Antibody (1.5 mg/kg;静脉注射;单次推注;首次给药后 63 天重复给药) 可诱导小鼠大型 CTG-1017 三阴性乳腺癌 PDX 异种移植物产生长期消退。

Animal Model: CB17/SCID (female, 5-6 weeks old, pancreatic cancer xenograft with 2 million BxPC3 cells implanted subcutaneously)
Dosage: 0.75 mg/kg; 1.5 mg/kg; 3.0 mg/kg
Administration: i.v.; single bolus injection
Result: Induced tumor regression at 1.5 mg/kg and 3.0 mg/kg doses.
Inhibited tumor growth at 0.75 mg/kg dose compared to controls.
Animal Model: CB17/SCID (female, pancreatic cancer PDX xenograft with 1-2 mm3 Pan0123 fragments implanted subcutaneously)
Dosage: 0.75 mg/kg; 1.5 mg/kg; 3.0 mg/kg
Administration: i.v.; single bolus injection/i.v.; every 2 weeks; 2 total doses
Result: Induced tumor regression at all tested single doses, with the most persistent regression seen at higher doses.
Animal Model: CB17/SCID (female, ovarian cancer PDX xenograft with 1-2 mm3 Ova196756 fragments implanted subcutaneously)
Dosage: 0.75 mg/kg; 1.5 mg/kg; 3.0 mg/kg
Administration: i.v.; single bolus injection
Result: Induced tumor regression at all tested single doses.
Induced more persistent regression and tumor eradication at doses ≥1.5 mg/kg.
Animal Model: CB17/SCID (female, lung cancer PDX xenograft with 1-2 mm3 LG0476 fragments implanted subcutaneously)
Dosage: 1.5 mg/kg
Administration: i.v.; single bolus injection
Result: Induced sustained tumor regression.
Showed superior efficacy over gemcitabine treatment (tumor regrew sooner) and paclitaxel treatment (only partial growth inhibition).
Animal Model: CB17/SCID (female, triple-negative breast cancer PDX xenograft with 1-2 mm3 CTG-1017 fragments implanted subcutaneously)
Dosage: 1.5 mg/kg
Administration: i.v.; single bolus injection; repeated 63 days after first dose
Result: Induced tumor regression lasting more than 60 days with the first single dose.
Induced another long-duration tumor regression after retreatment of regrown tumors.
性状 液体
颜色 Colorless to light yellow

化学信息

别名 RN927C antibody

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Shipping with dry ice.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础